Moving towards Supraspinal TRPV1 Receptors for Chronic Pain Relief
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Transient receptor potential vanilloid type 1 (TRPV1) receptor is a non selective ligand-gated cation channel activated by capsaicin, heat, protons and endogenous lipids termed endovanilloids. As well as peripheral primary afferent neurons and dorsal root ganglia, TRPV1 receptor is also expressed in spinal and supraspinal structures such as those belonging to the endogenous antinociceptive descending pathway which is a circuitry of the supraspinal central nervous system whose task is to counteract pain. It includes periaqueductal grey (PAG) and rostral ventromedial medulla (RVM) whose activation leads to analgesia. Such an effect is associated with a glutamate increase and the activation of OFF and inhibition of ON cell population in the rostral ventromedial medulla (RVM). Activation of the antinociceptive descending pathway via TPRV1 receptor stimulation in the PAG may be a novel strategy for producing analgesia in chronic pain. This review will summarize the more recent insights into the role of TRPV1 receptor within the antinociceptive descending pathway and its possible exploitation as a target for new pain-killer agents in chronic pain conditions, with particular emphasis on the most untreatable pain state: neuropathic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774 · cited 1×
“TRPV1 receptors have been identified in various regions of the brain known for their role in pain transmission or modulation [104-106] such as RVM, PAG, amygdala, solitary tract nucleus, somatosensory cortex, anterior cingulated cortex and insula [107,108].”
BackgroundMechanisms of neuropathic pain
Campbell, J. N., & Meyer, R. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.021 · Cited by 1,471
Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850
Deletion of vanilloid receptor 1_expressing primary afferent neurons for pain control
Karai, L., Brown, D. C., Mannes, A. J., Connelly, S. T., Brown, J., Gandal, M., Wellisch, O. M., Neubert, J. K., Olah, Z., & Iadarola, M. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20449 · Cited by 340
Gavva, N. R., Bannon, A. W., Hovland, D. N., Lehto, S. G., Klionsky, L., Surapaneni, S., Immke, D. C., Henley, C., Arik, L., Bak, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125674 · Cited by 180 · cited 2×
“Moreover, the magnitude and duration of temperature elevation caused by TRPV1 antagonists proved to be dependent on the specific properties (pharmacokinetic profile, specific modality of TRPV1 blockade) of the individual TRPV1 receptor antagonists [93,94].”
BackgroundRodella, L. F., Borsani, E., Rezzani, R., Ricci, F., Buffoli, B., & Bianchi, R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.031 · Cited by 32 · cited 1×
“It is not surprising then that the effectiveness of AM404, an inhibitor of endocannabinoid cellular uptake, in alleviating neuropathic pain has been attributed (at least in part) to TRPV1 receptor stimulation [96].”
Background
Cited by
Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo, V., & De Petrocellis, L. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0382 · Cited by 290
Roles of reactive oxygen and nitrogen species in pain
Salvemini, D., Little, J. W., Doyle, T., & Neumann, W. L. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.026 · Cited by 295
Barrière, D. A., Mallet, C., Blomgren, A., Simonsen, C., Daulhac, L., Libert, F., Chapuy, E., Etienne, M., Högestätt, E. D., Zygmunt, P. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070690 · Cited by 62
“…that intervention with spinal serotoninergic mechanisms prevents the antinociceptive effects of 4-aminophenol (present study) and paracetamol [12] provide additional evidence that supraspinal TRPV1 may regulate nociceptive neurotransmission via activation of descending bulbospinal pathways [32].”
Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey
Barrière, D. A., Boumezbeur, F., Dalmann, R., Cadeddu, R., Richard, D., Pinguet, J., Daulhac, L., Sarret, P., Whittingstall, K., Keller, M., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14934 · Cited by 34
Metadata
- Authors
- Palazzo, E., Luongo, L., de Novellis, V., Berrino, L., Rossi, F., & Maione, S.
- Venue
- Molecular Pain
- Publisher
- SAGE Publications
- Published
- 2010-01-01
- Volume
- 6
- Pages
- 66-66
- ISSN
- 1744-8069 (ISSN-L)
- OpenAlex
- W2168046655
- Cited by
- 85
- References
- 7
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moving towards Supraspinal TRPV1 Receptors for Chronic Pain Relief. https://app.cochat.ai/papers/10.1186/1744-8069-6-66
- The paper
- Palazzo, E., Luongo, L., de Novellis, V., Berrino, L., Rossi, F., & Maione, S. (2010). Moving towards Supraspinal TRPV1 Receptors for Chronic Pain Relief. Molecular Pain. https://doi.org/10.1186/1744-8069-6-66
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.